# Magnite, Inc.: financial statements, quarterly

MGNI · Nasdaq · CIK 1595974 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/mgni.md) · [Financials](/companies/mgni/financials.md) · [Filings](/companies/mgni/filings.md) · [Insiders](/companies/mgni/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/mgni/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [150](/filings/0001595974-24-000041.md) | [187 d](/filings/0001595974-26-000007.md) | [149](/filings/0001595974-25-000017.md) | [163](/filings/0001595974-25-000027.md) | [162](/filings/0001595974-25-000043.md) | [194 d](/filings/0001595974-26-000007.md) | [156](/filings/0001595974-26-000022.md) | [173](/filings/0001628280-26-053343.md) | [179](/filings/0001595974-25-000043.md) | [205 d](/filings/0001595974-26-000007.md) | [164](/filings/0001595974-26-000022.md) | [193](/filings/0001628280-26-053343.md) |
| Cost of revenue | $m | [84.9](/filings/0001595974-24-000041.md) | [70.0 d](/filings/0001595974-26-000007.md) | [65.9](/filings/0001595974-25-000017.md) | [62.6](/filings/0001595974-25-000027.md) | [62.5](/filings/0001595974-25-000043.md) | [67.8 d](/filings/0001595974-26-000007.md) | [62.8](/filings/0001595974-26-000022.md) | [65.0](/filings/0001628280-26-053343.md) | [69.4](/filings/0001595974-25-000043.md) | [69.5 d](/filings/0001595974-26-000007.md) | [60.4](/filings/0001595974-26-000022.md) | [62.0](/filings/0001628280-26-053343.md) |
| Research and development | $m | [23.5](/filings/0001595974-24-000041.md) | [23.2 d](/filings/0001595974-26-000007.md) | [26.9](/filings/0001595974-25-000017.md) | [25.8](/filings/0001595974-25-000027.md) | [20.3](/filings/0001595974-25-000043.md) | [22.3 d](/filings/0001595974-26-000007.md) | [22.3](/filings/0001595974-26-000022.md) | [21.6](/filings/0001628280-26-053343.md) | [20.2](/filings/0001595974-25-000043.md) | [20.6 d](/filings/0001595974-26-000007.md) | [25.2](/filings/0001595974-26-000022.md) | [24.1](/filings/0001628280-26-053343.md) |
| Operating income | $m | [(17.8)](/filings/0001595974-24-000041.md) | [35.1 d](/filings/0001595974-26-000007.md) | [(13.8)](/filings/0001595974-25-000017.md) | [9.6](/filings/0001595974-25-000027.md) | [15.1](/filings/0001595974-25-000043.md) | [40.2 d](/filings/0001595974-26-000007.md) | [(1.4)](/filings/0001595974-26-000022.md) | [22.0](/filings/0001628280-26-053343.md) | [25.0](/filings/0001595974-25-000043.md) | [52.0 d](/filings/0001595974-26-000007.md) | [7.7](/filings/0001595974-26-000022.md) | [31.2](/filings/0001628280-26-053343.md) |
| Interest expense | $m | [7.6](/filings/0001595974-24-000041.md) | [8.1 d](/filings/0001595974-26-000007.md) | [8.0](/filings/0001595974-25-000017.md) | [6.8](/filings/0001595974-25-000027.md) | [6.8](/filings/0001595974-25-000043.md) | [5.4 d](/filings/0001595974-26-000007.md) | [5.2](/filings/0001595974-26-000022.md) | [5.1](/filings/0001628280-26-053343.md) | [4.7](/filings/0001595974-25-000043.md) | [4.0 d](/filings/0001595974-26-000007.md) | [4.6](/filings/0001595974-26-000022.md) | [6.3](/filings/0001628280-26-053343.md) |
| Income tax | $m | [(1.0)](/filings/0001595974-24-000041.md) | [2.3 d](/filings/0001595974-26-000007.md) | [(7.8)](/filings/0001595974-25-000017.md) | [4.6](/filings/0001595974-25-000027.md) | [1.0](/filings/0001595974-25-000043.md) | [5.9 d](/filings/0001595974-26-000007.md) | [(0.9)](/filings/0001595974-26-000022.md) | [1.0](/filings/0001628280-26-053343.md) | [0.9](/filings/0001595974-25-000043.md) | [(75.0) d](/filings/0001595974-26-000007.md) | [(0.7)](/filings/0001595974-26-000022.md) | [6.2](/filings/0001628280-26-053343.md) |
| Net income | $m | [(17.5)](/filings/0001595974-24-000041.md) | [30.9 d](/filings/0001595974-26-000007.md) | [(17.8)](/filings/0001595974-25-000043.md) | [(1.1)](/filings/0001595974-25-000043.md) | [5.2](/filings/0001595974-25-000043.md) | [36.4 d](/filings/0001595974-26-000007.md) | [(9.6)](/filings/0001628280-26-053343.md) | [11.1](/filings/0001628280-26-053343.md) | [20.1](/filings/0001595974-25-000043.md) | [123 d](/filings/0001595974-26-000007.md) | [4.4](/filings/0001628280-26-053343.md) | [19.4](/filings/0001628280-26-053343.md) |
| Diluted EPS | $ per share | [(0.13)](/filings/0001595974-24-000041.md) | not reported | [(0.13)](/filings/0001595974-25-000017.md) | [(0.01)](/filings/0001595974-25-000027.md) | [0.04](/filings/0001595974-25-000043.md) | not reported | [(0.07)](/filings/0001595974-26-000022.md) | [0.08](/filings/0001628280-26-053343.md) | [0.13](/filings/0001595974-25-000043.md) | not reported | [0.03](/filings/0001595974-26-000022.md) | [0.13](/filings/0001628280-26-053343.md) |
| Basic EPS | $ per share | [(0.13)](/filings/0001595974-24-000041.md) | not reported | [(0.13)](/filings/0001595974-25-000017.md) | [(0.01)](/filings/0001595974-25-000027.md) | [0.04](/filings/0001595974-25-000043.md) | not reported | [(0.07)](/filings/0001595974-26-000022.md) | [0.08](/filings/0001628280-26-053343.md) | [0.14](/filings/0001595974-25-000043.md) | not reported | [0.03](/filings/0001595974-26-000022.md) | [0.14](/filings/0001628280-26-053343.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [311](/filings/0001595974-24-000041.md) | [326](/filings/0001595974-25-000008.md) | [253](/filings/0001595974-24-000022.md) | [326](/filings/0001595974-24-000032.md) | [387](/filings/0001595974-24-000041.md) | [483](/filings/0001595974-26-000007.md) | [430](/filings/0001595974-25-000017.md) | [426](/filings/0001595974-25-000027.md) | [482](/filings/0001595974-25-000043.md) | [553](/filings/0001628280-26-053343.md) | [185](/filings/0001595974-26-000022.md) | [333](/filings/0001628280-26-053343.md) |
| Current assets | $m | [1,269](/filings/0001595974-23-000039.md) | [1,523](/filings/0001595974-25-000008.md) | [1,273](/filings/0001595974-24-000022.md) | [1,468](/filings/0001595974-24-000032.md) | [1,573](/filings/0001595974-24-000041.md) | [1,703](/filings/0001595974-26-000007.md) | [1,515](/filings/0001595974-25-000017.md) | [1,757](/filings/0001595974-25-000027.md) | [1,726](/filings/0001595974-25-000043.md) | [1,882](/filings/0001628280-26-053343.md) | [1,648](/filings/0001595974-26-000022.md) | [1,746](/filings/0001628280-26-053343.md) |
| Total assets | $m | [2,445](/filings/0001595974-23-000039.md) | [2,689](/filings/0001595974-25-000008.md) | [2,454](/filings/0001595974-24-000022.md) | [2,643](/filings/0001595974-24-000032.md) | [2,738](/filings/0001595974-24-000041.md) | [2,855](/filings/0001595974-26-000007.md) | [2,675](/filings/0001595974-25-000017.md) | [2,927](/filings/0001595974-25-000027.md) | [2,921](/filings/0001595974-25-000043.md) | [3,164](/filings/0001628280-26-053343.md) | [2,947](/filings/0001595974-26-000022.md) | [3,033](/filings/0001628280-26-053343.md) |
| Current liabilities | $m | [1,131](/filings/0001595974-23-000039.md) | [1,402](/filings/0001595974-25-000008.md) | [1,155](/filings/0001595974-24-000022.md) | [1,329](/filings/0001595974-24-000032.md) | [1,414](/filings/0001595974-24-000041.md) | [1,496](/filings/0001595974-26-000007.md) | [1,538](/filings/0001595974-25-000017.md) | [1,765](/filings/0001595974-25-000027.md) | [1,713](/filings/0001595974-25-000043.md) | [1,842](/filings/0001628280-26-053343.md) | [1,621](/filings/0001595974-26-000022.md) | [1,704](/filings/0001628280-26-053343.md) |
| Total liabilities | $m | [1,793](/filings/0001595974-23-000039.md) | [1,987](/filings/0001595974-25-000008.md) | [1,759](/filings/0001595974-24-000022.md) | [1,930](/filings/0001595974-24-000032.md) | [2,012](/filings/0001595974-24-000041.md) | [2,087](/filings/0001595974-26-000007.md) | [1,933](/filings/0001595974-25-000017.md) | [2,159](/filings/0001595974-25-000027.md) | [2,113](/filings/0001595974-25-000043.md) | [2,242](/filings/0001628280-26-053343.md) | [2,029](/filings/0001595974-26-000022.md) | [2,097](/filings/0001628280-26-053343.md) |
| Long-term debt | $m | [602](/filings/0001595974-23-000039.md) | [533](/filings/0001595974-25-000008.md) | [549](/filings/0001595974-24-000022.md) | [549](/filings/0001595974-24-000032.md) | [550](/filings/0001595974-24-000041.md) | [550](/filings/0001595974-26-000007.md) | [349](/filings/0001595974-25-000017.md) | [349](/filings/0001595974-25-000027.md) | [348](/filings/0001595974-25-000043.md) | [348](/filings/0001628280-26-053343.md) | [347](/filings/0001595974-26-000022.md) | [347](/filings/0001628280-26-053343.md) |
| Current portion of debt | $m | [3.6](/filings/0001595974-23-000039.md) | [3.6](/filings/0001595974-24-000014.md) | [3.7](/filings/0001595974-24-000022.md) | [3.7](/filings/0001595974-24-000032.md) | [3.6](/filings/0001595974-24-000041.md) | [3.6](/filings/0001595974-26-000007.md) | [208](/filings/0001595974-25-000017.md) | [208](/filings/0001595974-25-000027.md) | [208](/filings/0001595974-25-000043.md) | [208](/filings/0001628280-26-053343.md) | [3.6](/filings/0001595974-26-000022.md) | [3.6](/filings/0001628280-26-053343.md) |
| Shareholders' equity | $m | [652](/filings/0001595974-24-000041.md) | [702](/filings/0001595974-26-000007.md) | [695](/filings/0001595974-25-000043.md) | [713](/filings/0001595974-25-000043.md) | [726](/filings/0001595974-25-000043.md) | [768](/filings/0001628280-26-053343.md) | [742](/filings/0001628280-26-053343.md) | [768](/filings/0001628280-26-053343.md) | [808](/filings/0001595974-25-000043.md) | [922](/filings/0001628280-26-053343.md) | [918](/filings/0001628280-26-053343.md) | [936](/filings/0001628280-26-053343.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent, us-gaap:DebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [82.1 d](/filings/0001595974-24-000041.md) | [89.1 d](/filings/0001595974-26-000007.md) | [(60.4)](/filings/0001595974-25-000017.md) | [89.6 d](/filings/0001595974-25-000027.md) | [91.3 d](/filings/0001595974-25-000043.md) | [115 d](/filings/0001595974-26-000007.md) | [2.6](/filings/0001595974-26-000022.md) | [18.5 d](/filings/0001628280-26-053343.md) | [86.6 d](/filings/0001595974-25-000043.md) | [128 d](/filings/0001595974-26-000007.md) | [(121)](/filings/0001595974-26-000022.md) | [187 d](/filings/0001628280-26-053343.md) |
| Capital expenditure | $m | [4.4 d](/filings/0001595974-24-000041.md) | [9.6 d](/filings/0001595974-26-000007.md) | [5.9](/filings/0001595974-25-000017.md) | [9.2 d](/filings/0001595974-25-000027.md) | [14.0 d](/filings/0001595974-25-000043.md) | [3.7 d](/filings/0001595974-26-000007.md) | [14.4](/filings/0001595974-26-000022.md) | [12.5 d](/filings/0001628280-26-053343.md) | [18.2 d](/filings/0001595974-25-000043.md) | [25.4 d](/filings/0001595974-26-000007.md) | [9.4](/filings/0001595974-26-000022.md) | [12.1 d](/filings/0001628280-26-053343.md) |
| Share repurchases | $m | [0.0 d](/filings/0001595974-24-000041.md) | [0.0 d](/filings/0001595974-26-000007.md) | [0.0](/filings/0001595974-25-000017.md) | [0.0 d](/filings/0001595974-25-000027.md) | [9.0 d](/filings/0001595974-25-000043.md) | [5.6 d](/filings/0001595974-26-000007.md) | [19.2](/filings/0001595974-26-000022.md) | [3.7 d](/filings/0001628280-26-053343.md) | [0.0 d](/filings/0001595974-25-000043.md) | [23.4 d](/filings/0001595974-26-000007.md) | [14.5](/filings/0001595974-26-000022.md) | [21.1 d](/filings/0001628280-26-053343.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [133](/filings/0001595974-23-000039.md) | [135](/filings/0001595974-24-000022.md) | [136](/filings/0001595974-24-000032.md) | [137](/filings/0001595974-24-000041.md) | [139](/filings/0001595974-25-000017.md) | [141](/filings/0001595974-25-000027.md) | [149](/filings/0001595974-25-000043.md) | [142](/filings/0001595974-26-000022.md) | [148](/filings/0001628280-26-053343.md) | [153](/filings/0001595974-25-000043.md) | [148](/filings/0001595974-26-000022.md) | [147](/filings/0001628280-26-053343.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 143,424,157 at 2026-07-29, from the cover of the [10-Q filed 2026-08-05](/filings/0001628280-26-053343.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:43 ET. No prices; not investment advice.